Comprehensive Support for UK Bioscience Business

OBN is a not-for-profit business network which provides comprehensive support for biotech and medtech companies in the Oxford and South-East England biocluster and beyond, providing networking, partnering, and group purchasing. Find out more about BioTrinity 2010 - our huge Biopartnering and Investment Conference, about OBN and download the BioCluster map.  Follow OBN on Twitter 

news  Enigma Diagnostics announces new San Diego office and appointment of Joel Centeno, VP regulatory & quality- 05 Mar 2010 BioVex initiates Phase 1 clinical trial with its genital herpes vaccine, ImmunoVEXHSV2- 05 Mar 2010 BioPark and ABS Laboratories announce a new 'open access' biomarker assay service- 04 Mar 2010 Archimedes Pharma announces major fundraising of £65 million- 03 Mar 2010 Appoints new Chief Executive Officer to accelerate growth of transatlantic business. US commerical operations to be established

more

OBN events  16 Mar 2010 - OBN BioTuesday March 16: Who should pay for the commercialization of University Research? 12 Apr 2010 - BioTrinity 2010: UK’s Premier Biotech and Investment Conference 25 May 2010 - May BioTuesday 22 Jun 2010 - Senior Executive Dinner 20 Jul 2010 - July BioTuesday

more

Other recommended events  17 Mar 2010 - Medical Innovation - A global perspective on healthcare innovation 17 Mar 2010 - Link China & UKTI jointly organizing CHINA Healthcare & Life Science 'Challenges and Opportunities' workshop at Granta Park 24 Mar 2010 - UK-Nordic Oncology Diagnostics Conference Enabling strategic oncology alliances with personalised medicine

more